Hyperkinetic movement disorders represent a heterogeneous group of disorders in which involuntary movements are the prevalent clinical symptoms. The five main categories of hyperkinetic disorders are tremor, dystonia, tics, myoclonus and drug-induced dyskinesia. The severity of hyperkinetic disorders is assessed by all clinicians when they examine a patient; quantifying the severity also provides a means of studying the natural history of a given disorder and the possible effect of new therapeutic interventions. This means that good rating instruments are required in both everyday practice and experimental settings. Unfortunately, the clinical evaluation of these disorders is complicated by the inherent nature and variability over time of involuntary movements. A number of scales have been proposed over the years to study the various hyperkinetic disorders. The aim of this review is to systematically identify all the clinical scales that have been proposed and to classify themaccording to the criteria developed by theMovement Disorder Society (MDS) task force for rating scales in Parkinson's disease.On the basis of thismethodology, a scale may be defined as Recommended, Suggested or Listed in decreasing order of value. We found that, although numerous scales aimed at assessing hyperkinetic disorders have been published, their variability in terms of clinimetric properties, availability and effort required to administer them is high. In this evaluation, we identified scales defined as Recommended for the assessment of all forms of hyperkinetic disorders. The situation highlighted by our analysis varies considerably, with several Recommended scales being available for some conditions such as tics or dystonia, but only one being available for myoclonus. This gap needs to be filled by the scientific community through both the development of new clinical tools and the refinement of existing ones.
Pietracupa, S., Bruno, E., Cavanna, A., Falla, M., Zappia, M., Colosimo, C. (2015). Scales for hyperkinetic disorders: A systematic review. JOURNAL OF THE NEUROLOGICAL SCIENCES, 358(1-2), 9-21 [10.1016/j.jns.2015.08.1544].
Scales for hyperkinetic disorders: A systematic review
Cavanna A;
2015
Abstract
Hyperkinetic movement disorders represent a heterogeneous group of disorders in which involuntary movements are the prevalent clinical symptoms. The five main categories of hyperkinetic disorders are tremor, dystonia, tics, myoclonus and drug-induced dyskinesia. The severity of hyperkinetic disorders is assessed by all clinicians when they examine a patient; quantifying the severity also provides a means of studying the natural history of a given disorder and the possible effect of new therapeutic interventions. This means that good rating instruments are required in both everyday practice and experimental settings. Unfortunately, the clinical evaluation of these disorders is complicated by the inherent nature and variability over time of involuntary movements. A number of scales have been proposed over the years to study the various hyperkinetic disorders. The aim of this review is to systematically identify all the clinical scales that have been proposed and to classify themaccording to the criteria developed by theMovement Disorder Society (MDS) task force for rating scales in Parkinson's disease.On the basis of thismethodology, a scale may be defined as Recommended, Suggested or Listed in decreasing order of value. We found that, although numerous scales aimed at assessing hyperkinetic disorders have been published, their variability in terms of clinimetric properties, availability and effort required to administer them is high. In this evaluation, we identified scales defined as Recommended for the assessment of all forms of hyperkinetic disorders. The situation highlighted by our analysis varies considerably, with several Recommended scales being available for some conditions such as tics or dystonia, but only one being available for myoclonus. This gap needs to be filled by the scientific community through both the development of new clinical tools and the refinement of existing ones.File | Dimensione | Formato | |
---|---|---|---|
Pietracupa-2015-J Neurological Sci-VoR.pdf
Solo gestori archivio
Descrizione: Review
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Licenza:
Tutti i diritti riservati
Dimensione
469.62 kB
Formato
Adobe PDF
|
469.62 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.